Wall Street firms adjusted their positions on major equities, with Piper Sandler upgrading Rivian and Mobileye to overweight while JPMorgan initiated coverage across several sectors, according to recent analyst reports.
Wall Street Upgrades Rivian and Mobileye to Overweight
Piper Sandler upgraded both Rivian and Mobileye to overweight from neutral, citing compelling valuations for both equities. According to Piper Sandler, Rivian benefits from a de-risked balance sheet, a smooth R2 ramp, and an improved demand outlook. Mobileye approaches a floor valuation while seizing control of its own destiny, the firm stated.
JPMorgan Initiates Biotech and Industrial Coverage
JPMorgan initiated coverage of Rhythm Pharmaceuticals with an overweight rating and a December 2027 price target of $145, stating that shares of the biotech company have room to run. The firm also initiated coverage of BWX Technologies with an overweight rating and a December 2027 price target of $230, citing a wide moat for the nuclear materials company. Additionally, JPMorgan initiated Cadre Holdings with an overweight rating and a December 2027 price target of $40, implying roughly 32% upside from current levels for the safety products company.
Jefferies and UBS Adjust Automotive and Energy Outlooks
Jefferies upgraded General Motors to buy from hold, pointing to robust free cash flow and confidence that 2027 will deliver over $10 billion in real free cash flow. Jefferies also upgraded Ford to buy from hold, stating that the stock sits at a margin trough with production set to normalize. Meanwhile, UBS upgraded Cameco to buy from neutral following a recent pullback of 18% over one month and 27% over six months, noting the drop stems from broader market sentiment rather than changing fundamentals.
Financial Institutions Issue Broad Sector Initiations
Piper Sandler initiated coverage of Williams-Sonoma as overweight with a $253 price target, calling the company best-in-class for carrying a top-tier EBIT margin during a depressed home furnishing industry backdrop. Citizens initiated Sonida Senior Living as market outperform with a $50 price target. Roth initiated Aduro Clean Technologies as a buy with a $30 price target, highlighting its platform chemistry technology that upgrades waste plastic and paraffinic crude into higher-value products. Phillip Capital upgraded Alphabet to buy from accumulate, maintaining a constructive view on the company’s long-term outlook despite near-term earnings revisions.
FAQ
Which companies did Piper Sandler upgrade?
Piper Sandler upgraded Rivian and Mobileye to overweight from neutral. The firm also initiated Williams-Sonoma and Arlo Technologies as overweight.
What is JPMorgan’s price target for Rhythm Pharmaceuticals?
JPMorgan issued a December 2027 price target of $145 for Rhythm Pharmaceuticals with an overweight rating.
Why did UBS upgrade Cameco?
UBS upgraded Cameco to buy from neutral following a recent market pullback, stating the drop was driven by broader market and AI-related sentiment rather than fundamentals.
Did You Know? Wall Street analysts frequently adjust price targets and ratings following quarterly earnings reports or shifts in broader macroeconomic sentiment, giving investors updated sector evaluations.
Want to stay ahead of market trends? Subscribe to our daily newsletter for the latest Wall Street upgrades, downgrades, and earnings insights.
Keep reading